CN1320921C - 贞芪扶正小水针 - Google Patents
贞芪扶正小水针 Download PDFInfo
- Publication number
- CN1320921C CN1320921C CNB2005100381945A CN200510038194A CN1320921C CN 1320921 C CN1320921 C CN 1320921C CN B2005100381945 A CNB2005100381945 A CN B2005100381945A CN 200510038194 A CN200510038194 A CN 200510038194A CN 1320921 C CN1320921 C CN 1320921C
- Authority
- CN
- China
- Prior art keywords
- injection
- ligustri lucidi
- fructus ligustri
- water
- astragalus root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002347 injection Methods 0.000 title claims abstract description 26
- 239000007924 injection Substances 0.000 title claims abstract description 26
- 229940107666 astragalus root Drugs 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims abstract description 8
- 241000830535 Ligustrum lucidum Species 0.000 title claims description 11
- 235000013399 edible fruits Nutrition 0.000 title claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 58
- 239000000243 solution Substances 0.000 claims abstract description 24
- 229930182490 saponin Natural products 0.000 claims abstract description 21
- 150000007949 saponins Chemical class 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 238000000605 extraction Methods 0.000 claims abstract description 16
- 239000008215 water for injection Substances 0.000 claims abstract description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 107
- 239000009636 Huang Qi Substances 0.000 claims description 28
- 238000001556 precipitation Methods 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 239000000047 product Substances 0.000 claims description 20
- 235000017709 saponins Nutrition 0.000 claims description 19
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 17
- 150000004676 glycans Chemical class 0.000 claims description 17
- 229920001282 polysaccharide Polymers 0.000 claims description 17
- 239000005017 polysaccharide Substances 0.000 claims description 17
- 239000002244 precipitate Substances 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 16
- 230000006837 decompression Effects 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 14
- 230000002421 anti-septic effect Effects 0.000 claims description 11
- 238000012856 packing Methods 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 10
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 claims description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 238000000638 solvent extraction Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 241001061264 Astragalus Species 0.000 claims description 6
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims description 6
- 239000012670 alkaline solution Substances 0.000 claims description 6
- 235000006533 astragalus Nutrition 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000012510 hollow fiber Substances 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 229960002242 chlorocresol Drugs 0.000 claims description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 3
- 229930014626 natural product Natural products 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 238000001802 infusion Methods 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 238000002203 pretreatment Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000001540 sodium lactate Substances 0.000 claims description 2
- 229940005581 sodium lactate Drugs 0.000 claims description 2
- 235000011088 sodium lactate Nutrition 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 1
- -1 antiseptic Substances 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 claims 1
- 230000003285 pharmacodynamic effect Effects 0.000 claims 1
- 238000000247 postprecipitation Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 8
- 238000005728 strengthening Methods 0.000 abstract description 6
- 238000009472 formulation Methods 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 238000001647 drug administration Methods 0.000 description 5
- 230000002950 deficient Effects 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 2
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000002242 deionisation method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100381945A CN1320921C (zh) | 2005-01-21 | 2005-01-21 | 贞芪扶正小水针 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100381945A CN1320921C (zh) | 2005-01-21 | 2005-01-21 | 贞芪扶正小水针 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1679817A CN1679817A (zh) | 2005-10-12 |
| CN1320921C true CN1320921C (zh) | 2007-06-13 |
Family
ID=35066823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100381945A Expired - Fee Related CN1320921C (zh) | 2005-01-21 | 2005-01-21 | 贞芪扶正小水针 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1320921C (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362170A (zh) * | 2001-01-02 | 2002-08-07 | 杨孟君 | 一种纳米贞芪扶正制剂药物及其制备方法 |
| CN1541699A (zh) * | 2003-11-07 | 2004-11-03 | 张晴龙 | 一种注射用参芪扶正冻干粉针剂及其制备方法 |
-
2005
- 2005-01-21 CN CNB2005100381945A patent/CN1320921C/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1362170A (zh) * | 2001-01-02 | 2002-08-07 | 杨孟君 | 一种纳米贞芪扶正制剂药物及其制备方法 |
| CN1541699A (zh) * | 2003-11-07 | 2004-11-03 | 张晴龙 | 一种注射用参芪扶正冻干粉针剂及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 中华人民共和国卫生部药品标准中药成方制剂 中华人民共和国卫生部药典委员会,117 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1679817A (zh) | 2005-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101214270B (zh) | 刺五加有效部位的提取物、其制备方法、其应用 | |
| CN103156869A (zh) | 从桑属植物提取的桑根酮c、桑根酮d及组合物的医药新用途 | |
| CN1872106A (zh) | 山香圆叶在治疗病毒性感冒疾病中的应用 | |
| CN1723981A (zh) | 罗汉果提取物用于制备药物辅料的新用途 | |
| CN1311864C (zh) | 贞芪扶正输液剂 | |
| CN1320921C (zh) | 贞芪扶正小水针 | |
| CN102920964A (zh) | 一种治疗咳嗽的中药制剂 | |
| CN1320920C (zh) | 注射用贞芪扶正冻干粉针制剂 | |
| CN101744993B (zh) | 人参、麦冬、五味子的提取方法及其制剂 | |
| CN101057890A (zh) | 一种治疗冠心病的中药组合物及其制备方法、制剂和其应用 | |
| CN1969945A (zh) | 补血中药制剂及其生产方法 | |
| CN101357213B (zh) | 复方斑蝥液体制剂及其制备方法 | |
| CN101745017B (zh) | 一种人参、麦冬以及五味子的提取方法及其制剂 | |
| CN101745016B (zh) | 一种"人参,麦冬和五味子"的提取方法及其制剂 | |
| CN1296072C (zh) | 一种治疗妇科疾病的药物制备方法 | |
| CN101375954B (zh) | 一种药物组合物、其制备方法及用途 | |
| CN101249129B (zh) | 一种治疗糖尿病的中药提取物组合物及其医药用途 | |
| CN104706708A (zh) | 红芪乙醇提取物在制备预防和治疗肝纤维化药物和保健品中的应用及其中有效成分鉴定方法 | |
| CN1475222A (zh) | 匙羹藤叶精提物及其制备工艺 | |
| CN112876522A (zh) | 一种雪莲黄酮类组合物的提取方法 | |
| CN112870242A (zh) | 雪莲黄酮类组合物在制备治疗关节炎疾病的药物中的用途 | |
| CN101181336A (zh) | 一种苦瓜降血糖有效部位的精制方法 | |
| CN101450105B (zh) | 一种当药制剂及其质量控制方法 | |
| CN1296073C (zh) | 一种治疗妇科疾病的药物制备方法 | |
| CN101744987B (zh) | 一种人参,麦冬与五味子的单独提取方法及其制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SUZHOU ERYE PARMACEUTICAL CO. LTD. Free format text: FORMER OWNER: ZOU QIAOGEN Effective date: 20100426 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 ROOM 102, UNIT 5, BUILDING 3, NO.40, TONGJIA LANE, GULOU DISTRICT, NANJING CITY, JIANGSU PROVINCE TO: 215002 NO.859, PANXU ROAD, SUZHOU CITY, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20100426 Address after: 215002 No. 859 Xu Cheng Road, Suzhou, Jiangsu Patentee after: SUZHOU ERYE PHARMACEUTICAL Co.,Ltd. Address before: Tong Xiang, Gulou District of Nanjing city in Jiangsu province 210009 No. 40 building 3 unit five Room 102 Patentee before: Zou Qiaogen |
|
| ASS | Succession or assignment of patent right |
Owner name: ZOU QIAOGEN Free format text: FORMER OWNER: SUZHOU ERYE PHARMACEUTICAL CO., LTD. Effective date: 20110722 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C56 | Change in the name or address of the patentee | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215002 ANMIN ROAD, DONGQIAO, HUANGDAI TOWN, XIANGCHENG DISTRICT, SUZHOU CITY, JIANGSU PROVINCE TO: 210009 BUILDING 8, NO. 26, MAJIA STREET, GULOU DISTRICT, NANJING CITY, JIANGSU PROVINCE |
|
| CP02 | Change in the address of a patent holder |
Address after: Xiangcheng District Wong Tai town bridge in Suzhou city of Jiangsu Province in 215002 min Road Patentee after: SUZHOU ERYE PHARMACEUTICAL Co.,Ltd. Address before: 215002 No. 859 Xu Cheng Road, Suzhou, Jiangsu Patentee before: SUZHOU ERYE PHARMACEUTICAL Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20110722 Address after: 8, building 26, 210009 Ma Jia street, Gulou District, Nanjing, Jiangsu Patentee after: Zou Qiaogen Address before: Xiangcheng District Wong Tai town bridge in Suzhou city of Jiangsu Province in 215002 min Road Patentee before: SUZHOU ERYE PHARMACEUTICAL Co.,Ltd. |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Yancheng Haijianuo Biological Engineering Co.,Ltd. Assignor: Zou Qiaogen Contract record no.: 2012320000615 Denomination of invention: Small injection of glossy privet fruit and astragalus root and its making method Granted publication date: 20070613 License type: Exclusive License Open date: 20051012 Record date: 20120518 |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20051012 Assignee: Yancheng Haijianuo Biological Engineering Co.,Ltd. Assignor: Zou Qiaogen Contract record no.: 2012320000615 Denomination of invention: Small injection of glossy privet fruit and astragalus root and its making method Granted publication date: 20070613 License type: Exclusive License Record date: 20120518 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070613 Termination date: 20140121 |